Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Ann N Y Acad Sci. 2017 Dec;1410(1):68–84. doi: 10.1111/nyas.13551

Table 1.

Summary of biomarker studies of LBP due to unspecified diagnoses

Year Study Comparator
groups
Number
of
subjects
(N)
Study design Summary of
significant
findings
Reference

1997 Bruunsgaard et al Eccentric vs. concentric exercise 9 Randomized control trial IL-6 increased after eccentric exercise. 34

1998 Ostrowski et al. Pre- and postintense prolonged exercise 16 Randomized control trail IL-6 increased post exercise: 35
Pre: 1.5 ± 0.7 pg/mL
Post: 94.4 ± 12.6 pg/mL

2005 Stürmer et al. Acute LBP/cLBP: low vs. high pain 72 (41 chronic, 31 acute) Longitudinal – prospective Acute LBP: increasing CRP with increasing pain (CRP: 1.6× higher in high-pain group). 26

2006 Gebhardt et al. Acute LBP cLBP 72 (41 chronic, 32 acute) Longitudinal – prospective Lower CRP with decreasing pain in acute LBP 27

2007 Rannou et al. Modic 0, I, II changes 85 Cross-sectional – prospective Serum hsCRP higher in modic I than 0 or II 42

2007 Uçeyler et al. Painless vs. painful neuropathy 32 painful, 20 painless, 38 healthy control Cross-sectional – prospective Painful group had 2× higher blood IL-2 and TNF-α mRNA levels than painless and control groups; 37
IL-10 mRNA levels 2× higher in painless group than painful.

2008 Wang et al. Chronic LBP and control 120 per group Longitudinal – prospective Higher proportion of chronic LBP patients had TNF-α level higher than 2 pg/mL as compared with controls 45

2010 Wang et al. Chronic LBP and control 29 per group Cross-sectional – prospective TNF-α levels were 25× higher in cLBP than controls. 46

2011 Park & Lee Pre- vs. posttreatment with ESI 55 Cross-sectional – prospective No correlation between hsCRP and VAS; 44
hsCRP reduced posttreatment compared with pretreatment.

2012 Goode et al. Graded scale of disc space narrowing (DSN), osteophyte formation (OST) in patients with and without LBP symptoms 547 Retrospective Type 11 collagen (C2C) was associated with DSN; 61
COMP was associated with DSN among patientss. with symptoms;
HA and C2C are correlated with DSN severity.

2012 Licciardone et al. Undefined chronic LBP by pain severity and number of osteopathic lesions 70 Substudy nested within random control trial IL-6 and IL-1β correlated with number of osteopathic lesions; 39
IL-6 correlated with LBP severity.

2014 Luchting et al. Chronic LBP vs. controls 10 Cross-sectional – prospective Increased frequency of Treg cells in CLBP patients compared with controls; 48
decreased frequency of TH17 in cLBP compared with controls.

2014 Rathod et al. Lumbar disc disease undergoing surgery and controls 50 lumbar, 50 control Longitudinal – prospective hsCRP almost 30× higher in lumbar disc disease patients compared with controls 43

2014 Sowa et al. Before vs. after exercise 43 Cross sectional – prospective RANTES correlated with pain and pain-related function after activity 47

2016 de Queiroz et al. Acute LBP by pain and disability 155 retrospective Positive correlations: 32
TNF-α and pain severity;
IL-6 and pain severity

2016 Deng et al. DH vs. control 10 Cross-sectional – prospective IL-6 higher in DH than controls; 78
Col II and aggrecan lower in DH than controls.

2016 Grad et al. Degenerated vs nondegenerated 80 Case control – prospective CCL5 was 1.6× higher in degenerated group compared with nondegenerated controls; 77
CXCL6 was 1.3× higher in degenerated group compared with controls

2016 Wang et al. Severe vs. mild sciatica 58 severe, 50 mild, 30 healthy control Cross sectional – prospective IL-6: 1.5× higher in severe than mild or control; 38
IL-8: higher in severe than control;
TNF-a: 2× higher in severe than mild or control;
IL-4: 2× higher in mild than severe or control;
IL-6: TNF-αa, IL-10 correlated with ODI